Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations

Antonio Cascio; Juan D. Colmenero; Javier Solera; Michael J. Corbel; Mohammad Reza Hasanjani Roushan; Mile Bosilkovski; Nikolaos V. Sipsas; Matthew E. Falagas; Ziad A. Memish; Javier Ariza; Antonio Cascio; Georgios Pappas; Ethan Rubinstein; Michael J. Corbel; Edward J. Young

Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations

Antonio Cascio, Juan D. Colmenero, Javier Solera, Michael J. Corbel, Mohammad Reza Hasanjani Roushan, Mile Bosilkovski, Nikolaos V. Sipsas, Matthew E. Falagas, Ziad A. Memish, Javier Ariza, Antonio Cascio, Georgios Pappas, Ethan Rubinstein, Michael J. Corbel, Edward J. Young

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Article

232 Citazioni (Scopus)

Abstract

Brucellosis remains the commonestanthropozoonosis worldwide, and itstreatment remains complex, requiringprotracted administration of morethan one antibiotic.• In November 2006, a consensusmeeting aimed at reaching a commonspecialist statement on the treatmentof brucellosis was held in Ioannina,Greece under the auspices of theInternational Society of Chemotherapyand the Institute of Continuing MedicalEducation of Ioannina.• The author panel suggests that theoptimal treatment of uncomplicatedbrucellosis should be based on asix-week regimen of doxycyclinecombined either with streptomycin for2–3 weeks, or rifampicin for six weeks.Gentamicin may be considered anacceptable alternative to streptomycin,while all other regimens/combinationsshould be considered second-line.• The development of a commonglobal therapeutic language forhuman brucellosis, and future,properly conducted clinical trialswould definitely solve controversiesregarding the disease.

Lingua originale	English
pagine (da-a)	1872-1878
Numero di pagine	7
Rivista	PLoS Medicine
Volume	4
Stato di pubblicazione	Published - 2007

All Science Journal Classification (ASJC) codes

Medicine(all)

Accesso al documento

OA Link

Fingerprint Entra nei temi di ricerca di 'Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations'. Insieme formano una fingerprint unica.

Cita questo

Cascio, A., Colmenero, J. D., Solera, J., Corbel, M. J., Roushan, M. R. H., Bosilkovski, M., Sipsas, N. V., Falagas, M. E., Memish, Z. A., Ariza, J., Cascio, A., Pappas, G., Rubinstein, E., Corbel, M. J., & Young, E. J. (2007). Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations. PLoS Medicine, 4, 1872-1878.

Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations. / Cascio, Antonio; Colmenero, Juan D.; Solera, Javier; Corbel, Michael J.; Roushan, Mohammad Reza Hasanjani; Bosilkovski, Mile; Sipsas, Nikolaos V.; Falagas, Matthew E.; Memish, Ziad A.; Ariza, Javier; Cascio, Antonio; Pappas, Georgios; Rubinstein, Ethan; Corbel, Michael J.; Young, Edward J.

In: PLoS Medicine, Vol. 4, 2007, pag. 1872-1878.

Risultato della ricerca: Article

Cascio, Antonio ; Colmenero, Juan D. ; Solera, Javier ; Corbel, Michael J. ; Roushan, Mohammad Reza Hasanjani ; Bosilkovski, Mile ; Sipsas, Nikolaos V. ; Falagas, Matthew E. ; Memish, Ziad A. ; Ariza, Javier ; Cascio, Antonio ; Pappas, Georgios ; Rubinstein, Ethan ; Corbel, Michael J. ; Young, Edward J. / Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations. In: PLoS Medicine. 2007 ; Vol. 4. pagg. 1872-1878.

@article{4d1b0b37f6a040b086a77a3cd52f9299,

title = "Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations",

abstract = "Brucellosis remains the commonestanthropozoonosis worldwide, and itstreatment remains complex, requiringprotracted administration of morethan one antibiotic.• In November 2006, a consensusmeeting aimed at reaching a commonspecialist statement on the treatmentof brucellosis was held in Ioannina,Greece under the auspices of theInternational Society of Chemotherapyand the Institute of Continuing MedicalEducation of Ioannina.• The author panel suggests that theoptimal treatment of uncomplicatedbrucellosis should be based on asix-week regimen of doxycyclinecombined either with streptomycin for2–3 weeks, or rifampicin for six weeks.Gentamicin may be considered anacceptable alternative to streptomycin,while all other regimens/combinationsshould be considered second-line.• The development of a commonglobal therapeutic language forhuman brucellosis, and future,properly conducted clinical trialswould definitely solve controversiesregarding the disease.",

author = "Antonio Cascio and Colmenero, {Juan D.} and Javier Solera and Corbel, {Michael J.} and Roushan, {Mohammad Reza Hasanjani} and Mile Bosilkovski and Sipsas, {Nikolaos V.} and Falagas, {Matthew E.} and Memish, {Ziad A.} and Javier Ariza and Antonio Cascio and Georgios Pappas and Ethan Rubinstein and Corbel, {Michael J.} and Young, {Edward J.}",

year = "2007",

language = "English",

volume = "4",

pages = "1872--1878",

journal = "PLoS Medicine",

issn = "1549-1277",

publisher = "Public Library of Science",

}

TY - JOUR

T1 - Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations

AU - Cascio, Antonio

AU - Colmenero, Juan D.

AU - Solera, Javier

AU - Corbel, Michael J.

AU - Roushan, Mohammad Reza Hasanjani

AU - Bosilkovski, Mile

AU - Sipsas, Nikolaos V.

AU - Falagas, Matthew E.

AU - Memish, Ziad A.

AU - Ariza, Javier

AU - Cascio, Antonio

AU - Pappas, Georgios

AU - Rubinstein, Ethan

AU - Corbel, Michael J.

AU - Young, Edward J.

PY - 2007

Y1 - 2007

N2 - Brucellosis remains the commonestanthropozoonosis worldwide, and itstreatment remains complex, requiringprotracted administration of morethan one antibiotic.• In November 2006, a consensusmeeting aimed at reaching a commonspecialist statement on the treatmentof brucellosis was held in Ioannina,Greece under the auspices of theInternational Society of Chemotherapyand the Institute of Continuing MedicalEducation of Ioannina.• The author panel suggests that theoptimal treatment of uncomplicatedbrucellosis should be based on asix-week regimen of doxycyclinecombined either with streptomycin for2–3 weeks, or rifampicin for six weeks.Gentamicin may be considered anacceptable alternative to streptomycin,while all other regimens/combinationsshould be considered second-line.• The development of a commonglobal therapeutic language forhuman brucellosis, and future,properly conducted clinical trialswould definitely solve controversiesregarding the disease.

AB - Brucellosis remains the commonestanthropozoonosis worldwide, and itstreatment remains complex, requiringprotracted administration of morethan one antibiotic.• In November 2006, a consensusmeeting aimed at reaching a commonspecialist statement on the treatmentof brucellosis was held in Ioannina,Greece under the auspices of theInternational Society of Chemotherapyand the Institute of Continuing MedicalEducation of Ioannina.• The author panel suggests that theoptimal treatment of uncomplicatedbrucellosis should be based on asix-week regimen of doxycyclinecombined either with streptomycin for2–3 weeks, or rifampicin for six weeks.Gentamicin may be considered anacceptable alternative to streptomycin,while all other regimens/combinationsshould be considered second-line.• The development of a commonglobal therapeutic language forhuman brucellosis, and future,properly conducted clinical trialswould definitely solve controversiesregarding the disease.

UR - http://hdl.handle.net/10447/381309

M3 - Article

VL - 4

SP - 1872

EP - 1878

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

ER -